Amarin Corp Plcuk (AMRN) Equity Average (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Equity Average of $454.3 million for Q1 2026, down 5.33% year-over-year from $479.9 million in Q1 2025, and down 1.03% quarter-over-quarter from $459.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Equity Average (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Equity Average data on file, last reported at $454.3 million in Q1 2026.

  • Equity Average for Q1 2026 came in at $454.3 million, down 5.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $454.3 million (down 5.33% YoY), and the FY2025 annual result was $472.7 million, down 8.94% from the prior year.
  • Equity Average declined to $454.3 million in Q1 2026 per AMRN's latest filing, from $459.1 million in the prior quarter.
  • Over five years, Equity Average peaked at $654.1 million in Q1 2022 and troughed at $454.3 million in Q1 2026.
  • A 5-year average of $540.8 million and a median of $549.0 million in 2024 frame the typical range for Equity Average.
  • The sharpest annual moves came in 2022 and 2025: Equity Average climbed 3.65% in 2022, then slipped 14.72% in 2025.
  • A 5-year view of Equity Average shows it stood at $591.6 million in 2022, then retreated by 6.59% to $552.6 million in 2023, then decreased by 7.93% to $508.8 million in 2024, then declined by 9.77% to $459.1 million in 2025, then dropped by 1.03% to $454.3 million in 2026.
  • Business Quant data shows AMRN's Equity Average at $454.3 million in Q1 2026, $459.1 million in Q4 2025, and $461.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 28.87 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 81.37 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -4.96 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 49.27 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 8.92 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 23.11 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 88.29 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 19.27 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 454.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 454.35 Mn
Dec 31, 2025 459.09 Mn
Sep 30, 2025 461.91 Mn
Jun 30, 2025 469.31 Mn
Mar 31, 2025 479.93 Mn
Dec 31, 2024 508.78 Mn
Sep 30, 2024 541.63 Mn
Jun 30, 2024 548.91 Mn
Mar 31, 2024 549.02 Mn
Dec 31, 2023 552.62 Mn
Sep 30, 2023 561.14 Mn
Jun 30, 2023 576.96 Mn
Mar 31, 2023 590.06 Mn
Dec 31, 2022 591.58 Mn
Sep 30, 2022 583.94 Mn
Jun 30, 2022 610.58 Mn
Mar 31, 2022 654.10 Mn
Dec 31, 2021 654.80 Mn
Sep 30, 2021 643.91 Mn
Jun 30, 2021 639.97 Mn